急性B型主动脉夹层与壁内血肿的比较结局:手术与腔内治疗启示
单中心回顾性分析131例急性B型主动脉综合征患者(夹层52例,壁内血肿79例),比较介入与药物治疗结局。壁内血肿患者年龄更大,TEVAR可促进有利重塑但不改善生存,无症状夹层进行性扩大提示早期TEVAR可能有益。
要点
- 壁内血肿患者年龄显著大于夹层患者(70.6±12.3 vs 60.5±16.1岁,P=0.0002)
- TEVAR促进两种疾病有利重塑但不改善生存
- 无症状夹层进行性扩大提示早期TEVAR可能有益
核心结论
- 尽管指南相似,急性B型主动脉夹层与壁内血肿表现出不同的重塑模式。
- 保守治疗对部分无并发症病例仍有效,TEVAR改善重塑但无生存获益。
- 无并发症夹层进行性扩大提示早期TEVAR有益。
研究设计与样本
- 单中心回顾性研究,纳入2008至2025年治疗的131例急性B型主动脉综合征患者(夹层52例,壁内血肿79例)。
- 患者分为介入组(TEVAR)和药物组,在3个胸廓水平行标准化CT随访,采用平滑和混合效应回归评估主动脉增长。
主要发现
- 壁内血肿患者年龄大于夹层患者(70.6±12.3 vs 60.5±16.1岁;P=0.0002),早期TEVAR率分别为28.8%和24.1%。
- 药物管理患者中,夹层和壁内血肿分别有13.5%和6.7%出现延迟干预。
- 干预指征不同:夹层为进行性扩大,壁内血肿为异质性原因。
- 平均干预时间夹层更长(18.5个月;排除一例离群值后3.2个月) than 壁内血肿(3.0个月)。
- 主动脉直径变化与夹层假腔厚度和壁内血肿血肿厚度强相关。
关键数值与推荐
- 壁内血肿患病率高于西方队列,与亚洲数据一致。
临床怎么用
- 对无并发症病例可考虑保守治疗,TEVAR用于促进重塑而非延长生存。
- 无并发症夹层出现进行性扩大时应考虑早期TEVAR。
局限性
- 回顾性单中心设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute type B aortic syndrome (ATBAS), including type B aortic dissection (AD) and intramural hematoma (IMH), shares management guidelines; however, their natural history may differ. Comparative single-center data are limited. METHODS: We retrospectively reviewed 131 patients with ATBAS (52 with AD and 79 with IMH) treated from 2008 to 2025. Patients were stratified into interventional (thoracic endovascular aortic repair [TEVAR]) and medical groups. Serial computed tomography at 3 thoracic levels was performed using standardized protocols, with aortic growth assessed by smoothing and mixed-effects regression. RESULTS: Patients with IMH were older than those with AD (70.6 ± 12.3 vs. 60.5 ± 16.1 years; P = 0.0002), with modest early TEVAR rates (28.8% vs. 24.1%). Among medically managed patients, delayed intervention occurred in 13.5% and 6.7% of patients with AD and IMH. Indications differed: progressive enlargement in AD and heterogeneous causes in IMH. Mean time to intervention was longer in patients with AD (18.5 months; 3.2 months excluding one outlier) than in those with IMH (3.0 months). TEVAR promoted favorable remodeling in both diseases but did not improve survival. IMH prevalence was higher than that in Western cohorts, aligning with Asian data. Changes in the aortic diameter were strongly linked to false lumen thickness in AD and hematoma thickness in IMH. CONCLUSION: Despite similar guidelines, AD and IMH exhibit distinct remodeling patterns. Conservative therapy remains effective in selected uncomplicated cases, whereas TEVAR improves remodeling without a survival benefit. Progressive enlargement in uncomplicated AD suggests that performing TEVAR in early stages is beneficial.
引用
- Jeon BH, Yoon TH, Kim KH, et al. Comparative Outcomes of Acute Type B Aortic Dissection and Intramural Hematoma: Implications for Surgical and Endovascular Management. Ann Vasc Surg. 2025. PMID: 41223940. doi:10.1016/j.avsg.2025.10.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。